HBM Healthcare Investments and Samsara BioCapital led a $36m series A financing round in Mineralys Therapeutics.

Synopsis

HBM Healthcare Investments and Samsara BioCapital, two venture capital firms, led a $36m series A financing round in Mineralys Therapeutics, an American biotech firm.

Principals

target

Mineralys Therapeutics

bidder

Hbm Healthcare Investments

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

latham & watkins

HQ - New York, United States

legal advisors

target

5719

Deals

£ 3,805.88 B

Total Value